Status:
COMPLETED
Identifying Risk Factors for Developing AKI in Sepsis
Lead Sponsor:
Cardiff and Vale University Health Board
Conditions:
Sepsis
Acute Kidney Injury
Eligibility:
All Genders
Up to 18 years
Brief Summary
A study to evaluate the prevalence of Acute Kidney Injury (AKI) in patients with Diabetic Ketoacidosis (DKA) and sepsis using data collected prospectively to a patient registry. The primary objective ...
Detailed Description
It is a descriptive study to report the prevalence ofAcute Kidney Injury ( AKI) in the two cohorts of sepsis and Diabetic Ketoacidosis ( DKA). In addition we aim to evaluate the relation with hyperchl...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Children under 16 years and admitted to PCCU or wards in the past 5 years
- Diagnosis of DKA or Sepsis/severe bacterial infection/septic shock
- DKA - defined as per the British Society for Paediatric Endocrinology and Diabetes (BSPED) guidance. Sepsis is defined based on the International Pediatric Sepsis Consensus Conference guidance (2005)
- 3. Exclusion Criteria
- Any patients identified as above but not able to obtain case notes for any reason.
- Patients with pre-existing kidney conditions
- Patients with inborn errors of metabolism
Exclusion
Key Trial Info
Start Date :
March 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04825639
Start Date
March 15 2021
End Date
March 31 2022
Last Update
July 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Noah's Ark Children's hospital
Cardiff, South Glamorgan, United Kingdom, CF14 4XW